Log in to save to my catalogue

Fe(II) and tannic acid-cloake MOF as carrier of artemisinin for supply of ferrous ions to enhance tr...

Fe(II) and tannic acid-cloake MOF as carrier of artemisinin for supply of ferrous ions to enhance tr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2539362613

Fe(II) and tannic acid-cloake MOF as carrier of artemisinin for supply of ferrous ions to enhance treatment of triple-negative breast cancer

About this item

Full title

Fe(II) and tannic acid-cloake MOF as carrier of artemisinin for supply of ferrous ions to enhance treatment of triple-negative breast cancer

Publisher

Durham: Research Square

Journal title

Nanoscale Research Letters, 2020

Language

English

Publication information

Publisher

Durham: Research Square

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Suppression of tumor development by inducing ferroptosis may provide a potential remedy for triple-negative breast cancer (TNBC), which is sensitive to intracellular oxidative imbalance. Recently, artemisinin (ART) and its derivatives have been investigated as potential anticancer agents for the treatment of highly aggressive cancers via the induct...

Alternative Titles

Full title

Fe(II) and tannic acid-cloake MOF as carrier of artemisinin for supply of ferrous ions to enhance treatment of triple-negative breast cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2539362613

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2539362613

Other Identifiers

DOI

10.21203/rs.3.rs-77012/v1